Global Synthetic Biology Market: Overview
Synthetic biology is the advanced technology that is developed from biology, engineering, chemistry, and computer science but the approach was ultimately changed towards therapeutics. The various application of synthetic biology includes industrial enzymes, bio-based chemicals, biofuels, vaccine and antibody production, and synthetic biology life science research. The biological systems are developed by molding the core components such as part of enzymes, genetic circuits, and metabolic pathways. At first, the smaller parts or devices are studied and their performance is checked before putting them into integrated systems. New medicines are produced with the help of synthetic biology on the cellular, molecular and then genetic level.
Global Synthetic Biology Market: Segmentation
The global synthetic biology market is segregated into a product, technology, and applications. On the basis of product, the synthetic biology market is segregated into core products, DNA & RNA purification kits, and recombinant proteins. The core products are further sub-segmented into synthetic cells, synthetic DNA, and synthetic genes. Based on the technology, the market is categorized into genome engineering, mutagenesis, and DNA sequencing. On the basis of applications, the global market is divided into universities, research organizations, pharmaceutical companies, and chemical industries.
Global Synthetic Biology Market: Growth Factors
Companies across the globe are investing in the synthetic biology owing to the reason that the governmental bodies are turning their focus towards climate change and biomass. In the recent years, many industries have started to take interest in the synthetic biology due to its large scale applications and its potential to generate new editing techniques of the gene are some reasons that are driving the market growth. DNA synthesis technologies and DNA sequencing and genetically engineered products are replacing the traditional medicines. Advanced computing and design systems in synthetic biology have completely changed the traditional approach of fighting against the genetic challenges and newer diseases. Though the synthetic biology market has great potential but still there are factors that hamper the market growth which includes government regulations and policies, bio-war, and biosafety and biosecurity issues.
Global Synthetic Biology Market: Regional Analysis
The synthetic biology market is diversified into regions such as North America, Asia-Pacific, Europe, and Rest of the World. The region that dominates the synthetic biology market is the North America. North America Defense is the main investor in the synthetic biology market. European market players are also investing in the synthetic biology market for developing a synthesis of biologically inspired or biologically based systems. In the Asia Pacific region, emerging countries such as China and India are contributing a good share in the market development and growth.
Global Synthetic Biology Market: Competitive Players
The key market players in the synthetic biology market include DuPont, Intrexon Corporation, New England Biolabs, Inc., Royal DSM, Thermo Fisher Scientific, Inc., Amyris, Inc., GenScript USA, Inc., Integrated DNA Technologies (IDT), Novozymes, Synthetic Genomics, Inc.
Global Synthetic Biology Market: Regional Segment Analysis
What Report Provides